Stocks & Investing
Stocks and Investing
Stocks and Investing
Mon, July 25, 2022
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
[ Mon, Jul 25th 2022
] - WOPRAI
Vikram Purohit Maintained (TBPH) at Sell with Decreased Target to $10 on, Jul 25th, 2022
Vikram Purohit of Morgan Stanley, Maintained "Theravance Biopharma, Inc." (TBPH) at Sell with Decreased Target from $11 to $10 on, Jul 25th, 2022.
Vikram has made no other calls on TBPH in the last 4 months.
There is 1 other peer that has a rating on TBPH. Out of the 1 peers that are also analyzing TBPH, 0 agree with Vikram's Rating of Hold.
This is the rating of the analyst that currently disagrees with Vikram
- David Risinger of "SVB Leerink" Initiated at Buy and Held Target at $12 on, Monday, May 23rd, 2022
